AgeX

$1.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-7.56%) Today
-$0.02 (-1.26%) As of 7:59 PM EDT after-hours

Why Robinhood?

You can buy or sell AgeX and other stocks, options, and ETFs commission-free!

About AGE

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Read More Its technology platforms include PureStem, UniverCyte, iTR and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. The listed name for AGE is AgeX Therapeutics, Inc.

CEO
Michael D. West
Employees
17
Headquarters
Alameda, California
Founded
2017
Market Cap
59.92M
Price-Earnings Ratio
Dividend Yield
Average Volume
543.36K
High Today
$1.67
Low Today
$1.55
Open Price
$1.66
Volume
356.62K
52 Week High
$3.93
52 Week Low
$0.666

Collections

AGE Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 12, After Hours

You May Also Like